Delivery Order SPE2DB24D2205-SPE2DB25FEHDZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $3,198.50, was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 per unit, with a ceiling value of $1,709.94. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,540.08 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a completion deadline of April 30, 2025. This competitively awarded, firm fixed-price contract was issued on April 29, 2025, with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30-tablet units, with a contract ceiling value of $13,740.06. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion on September 12, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Xeljanz XR 11mg tablets (30-count bottles) under a firm fixed-price contract with a ceiling value of $43,030.67. This non-set-aside delivery order is scheduled for completion by October 1, 2025, with performance at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a ceiling value of $5,651.30. This is a firm fixed-price delivery order with a completion deadline of September 12, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30-count units, with a contract ceiling value of $117,392.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a ceiling value of $6,576.04 and an ultimate completion date of May 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competed through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This $5,118.27 firm fixed price delivery order, with a completion date of May 8, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and the pharmaceutical products will be delivered to...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHDZDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside order carries a ceiling value of $11,698.84 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The order will be fulfilled at the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. Through this contracting vehicle, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a critical vendor within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 9/5/25 |